CompletedPhase 2NCT00745199

Evaluating the Effect of Cromolyn Sodium in Uremic Pruritus

Studying Uremic pruritus

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Shiraz University of Medical Sciences
Principal Investigator: Ghazal Vessal, PharmD, BCPS, PHARMACIST
Shiraz University of Medical Sciences
Intervention: cromolyn sodium(drug)
Enrollment: 62 target
Eligibility: 18-75 years · All sexes
Timeline: 2008 – 2009

Study locations (1)

Shiraz University of Medical sciences, Nemazi and Faghihi Hospital, Shiraz, Fars, Iran

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00745199 on ClinicalTrials.gov

Other trials for Uremic pruritus

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE3NCT06446310
Phase 3 Study of QLG2198 in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
Qilu Pharmaceutical (Hainan) Co., Ltd.

See all trials for Uremic pruritus →

← Back to all trials